Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-762-1 | CAS number: 6358-09-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Oct. 10, 1989 to Oct. 17, 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Well documented study, followed guideline with deviations, GLP (3 animal/sex/group were used against the guideline recommendation of a minimum of 4 animals of one sex/group; exposure period of 30 min is less when compared to guideline recommendation of 6 or 24 hour exposure period)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- (3 animal/sex/group were used against the guideline recommendation of a minimum of 4 animals of one sex/group; exposure period of 30 min is less when compared to guideline recommendation of 6 or 24 hour exposure period)
- GLP compliance:
- yes
Test material
- Reference substance name:
- 2-amino-6-chloro-4-nitrophenol
- EC Number:
- 228-762-1
- EC Name:
- 2-amino-6-chloro-4-nitrophenol
- Cas Number:
- 6358-09-4
- Molecular formula:
- C6H5ClN2O3
- IUPAC Name:
- 2-amino-6-chloro-4-nitrophenol
- Reference substance name:
- Chlororange
- IUPAC Name:
- Chlororange
- Reference substance name:
- 6-chloro-4-nitro-2-aminophenol
- IUPAC Name:
- 6-chloro-4-nitro-2-aminophenol
- Details on test material:
- RADIOLABELED TEST MATERIAL
- Name of test material: 6-chloro-4-nitro-2-aminophenol-UL-14C; Chlororange
- Substance type: Pure active substance
- Physical state: Yellow powder
- Specific activity: 13.7 mCi/mmol
- Locations of the label: Ring
- Storage: Store in the refrigerator at about 5°C.
Constituent 1
Constituent 2
Constituent 3
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Wella AG ; n°Batch O99F9213
- Expiration date of the lot/batch: No data
- Purity test date: No data
- Purity : >98%
RADIOLABELLING INFORMATION (if applicable)
- Radiochemical purity: >98%
- Specific activity: 13.7 mCi/mmol
- Locations of the label: Ring-14C
- Expiration date of radiochemical substance: No data
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: in the refrigerator at about 5°C (radioactive substance) - room temperature (inactive test substance)
- Stability under test conditions: No data
- Solubility and stability of the test substance in the solvent/vehicle: No data
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: No data
TREATMENT OF TEST MATERIAL PRIOR TO TESTING : No - Radiolabelling:
- yes
- Remarks:
- Ring-14C
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley, Him:OFA, SPF
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Forschungsinstitut für Versuchstierzucht, A-2325 Himberg, Austria.
- Age at study initiation: Not reported
- Weight at study initiation: Approximately 200 g
- Fasting period before study: None
- Housing: Individually in metabolism cages
- Individual metabolism cages: yes
- Diet: Altromin 1311ff diet for rats, ad libitum
- Water: Tap water in Makrolon bottles with stainless steel canules, ad libitum
- Acclimation period: 1 week
Random samples of the feed were analysed for contaminants by Altromin, D-4937 Lage.
ENVIRONMENTAL CONDITIONS
- Temperature: Average of 21°C
- Humidity: Average of 45%
- Air changes (per hr): 10/hour
- Photoperiod: Artificial light from 6.00 a.m. to 6.00 p.m.
IN-LIFE DATES: From: Oct. 10, 1989 To: Oct. 17, 1989
Administration / exposure
- Route of administration:
- dermal
- Vehicle:
- other: Hair Dye Formulations I and II (Formulation II with and without Welloxon)
- Details on exposure:
- PREPARATION OF TEST SUBSTANCE FORMUALTIONS/SOLUTION: Two studies (Study A and B) were conducted using the radiolabeled test substance. In Study A and B, formulation 1 and 2 were used, respectively. In Study C, solution of test substance in water/DMSO was used. The details of test formulation or solution were as follows:
Formulation 1: Formulation without H2O2 containing 3% radiolabeled test substance.
Formulation 2: Formulation with H2O2 containing 3% radiolabeled test substance.
Solution of test substance: 9.99% solution of the radiolabeled test substance in water/DMSO (1:1).
TEST SITE
- Preparation of test site: Animals were shaved with electric clippers the day before treatment. Animals were anesthetized with Thiopental prior to treatment.
- Area of exposure: 9 sq cm
- Application of the solution: Formulations were applied by spreading evenly (until the skin was wetted) with a spatula and the solution was applied using a plastic syringe.
REMOVAL OF TEST SUBSTANCE
- Washing: The formulation or the solution was left for 30 min and was then scraped off using a spatula, followed by a rinse-off using first about 100 mL of a 3 % solution of a proprietary shampoo and then water. Rinsing was continued until the rinsing water and the absorbent cellulose tissue which was used to dab the skin dry were free of colour. After rinsing, the area was covered with gauze fixed by adhesive tape and an additional air permeable plastic cone to further prevent licking of the treated area during the 72 h in the metabolism cages.
- Time after start of exposure: 30 min
TEST MATERIAL
- Amount(s) applied: 30.0 mg/animal (study A); 29.3 mg/animal (study B); 30.3 mg/animal (study C)
USE OF RESTRAINERS FOR PREVENTING INGESTION: During the exposure time, animals were fixed to avoid licking.
HOMOGENEITY AND STABILITY OF TEST MATERIAL:
Six samples of each of the formulations and of the solution of the test substance were drawn to check the homogeneity and also to determine the specific radioactivity. The latter was used to calculate the actual applied 14C-dose. Samples of the formulations and the solution were dissolved and diluted with Insta-Gel scintillator, Packard Instrument Co. - Duration and frequency of treatment / exposure:
- Once, 30 min application
Doses / concentrationsopen allclose all
- Dose / conc.:
- 2.28 other: mg/cm²
- Remarks:
- Study A
Doses / Concentrations:
- Mean mass of formulation or solution applied per animal: 1.0 g (Study A)
- Mean mass of the test substance applied per animal: 30.0 mg (Study A)
- Mean mass of the test substance applied per cm2: 2.28 mg (Study A)
- Mean specific activity of the formulations or the solution: 7.544 MBq/g (Study A)
- Dose / conc.:
- 3.26 other: mg/cm²
- Remarks:
- Doses / Concentrations:
- Mean mass of formulation or solution applied per animal: 0.99 g (Study B)
- Mean mass of the test substance applied per animal: 29.3 mg (Study B)
- Mean mass of the test substance applied per cm2: 3.26 mg (Study B)
- Mean specific activity of the formulations or the solution: 5.285 MBq/g (Study B)
- Dose / conc.:
- 3.37 other: mg/cm²
- Remarks:
- Doses / Concentrations:
- Mean mass of formulation or solution applied per animal: 0.303 g (Study C)
- Mean mass of the test substance applied per animal: 30.3 mg (Study C)
- Mean mass of the test substance applied per cm2:3.37 mg (Study C)
- Mean specific activity of the formulations or the solution: 13.673 MBq/g (Study C)
- No. of animals per sex per dose / concentration:
- 3
- Control animals:
- no
- Positive control reference chemical:
- None
- Details on study design:
- - Dose selection rationale: The doses were chosen considering practical conditions of hair dyeing in humans.
- Rationale for animal assignment: Animal numbers were allocated using a table of random numbers. - Details on dosing and sampling:
- PHARMACOKINETIC STUDY (absorption, distribution, excretion)
- Tissues and body fluids sampled: Rinsing water, treated skin, urine, faeces, organs, carcass.
- Time and frequency of sampling: Urine and faeces were collected daily (0-24, 24-48 and 48-72 h p.a.) from the metabolism cages. Water from the daily rinsing of the cages was combined with urine. Urine and faeces that were passed during the exposure period were recovered. Faeces were mixed with water and then homogenized.
SACRIFICE: The animals were killed 72 hours after the application by exsanguination in anesthesia (Thiopental).
RINSINGS: Application site washings (rinsings), consisted of scraped off formulations dissolved in methanol/water 1:1, solution of shampoo, rinsing water, methanol/water 1:1 extracts of the absorbent tissue used for drying the skin. These rinsing were filtered and 14C-content of filter and filtrate were determined separately and were then combined by calculation.
COLLECTION AND PROCESSING OF SAMPLES: The samples collected were processed prior to radioanalysis as follows:
- Application site: The dyed area plus some surrounding skin was dissolved in Soluene-350, Packard Instrument Co.
- Organs taken: adrenals, blood, brain, fat, femur, heart, kidneys, liver, lungs, muscle, ovaries, skin (untreated), spleen, testes and thyroids.
- Carcass: The skin of the animal was completely removed, to avoid false 14C-concentrations in the carcass due to skin. The residual carcass was homogenized together with the rest of the organs in an electric meat mincer by forcing them several times through the device.
DETERMINATION OF RADIOACTIVITY:
- Filters and weighed aliquots of faeces, organs and carcass were air dried and then combusted in a Sample Oxidizer 306, Packard Instrument Co.
- 14C-hexadecane standards of known radioactivity were combusted after each series of 15 - 30 samples to determine the recovery and to check the carry-over. This recovery was used to correct the sample activity.
- Liquid samples (urine, filtrate of rinsing, dissolved test substance) were incorporated into the liquid scintillator Insta-Gel (Packard Instrument Co.), dissolved skin from the injection site in Permafluor V (Packard Instrument Co.).
- Double determinations were performed of faeces, carcass, adrenals, ovaries and thyroids.
- Double or multiple determinations of other samples were performed if the result of the first determination required verification.
ANALYSIS OF SAMPLES: 14C was determined in a liquid scintillation counter (Tri-Carb 300CD, Packard Instrument Co.) with automatic external standardization and facilities to subtract background counting rates and to compute quench corrected decay rates.
- Statistics:
- T-test was used for analysis of differences between the sexes and the studies (p = 0.05).
Results and discussion
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- Absorption through dermal route was low.
- Type:
- distribution
- Results:
- The test substance concentration was near or below the detection limits in all analyzed organs.
- Type:
- excretion
- Results:
- The test substance was mainly excreted by urine.
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- - The mean absorption was low in studies A (0.248% or 5.6 μg/cm²) and B (0.189% or 3.52 μg/cm²), it was statistically significant higher in study C (1.213% or 40.0 μg/cm²) where the test substance solution was applied. The absorption was also transformed into absolute terms (i.e. microgram equivalents of the test substance per square cm).
- The percutaneous absorption at the site of application (mean 14C-content) was 0.38, 0.82 and 0.59% of the administered 14C-amount 3 days post-administration in studies A, B and C, respectively. The mean 14C-content of the skin in study B was statistically significantly higher than that found in study A.
- The majority of the applied 14C was removed from the skin by rinsing 30 min after the beginning of the cutaneous treatment (means of 95.4 to 98.7%). - Details on distribution in tissues:
- - Organs: After cutaneous application all mean concentrations of 14C in the organs 72 hours post-dose were near or below the detection limits. In studies A to C relatively highest concentrations were noted in thyroids (below detection limits) and kidneys. Lowest concentrations were detected in lungs, brain and heart in study A and in testes, brain and muscle in studies B and C.
- Carcass: The remaining mean amounts of 14C in the carcass 3 days after cutaneous application were very low and below or near the detection limit in studiesA and B. In study C they were slightly above the detection limit. The mean percentage of the administered 14C-amounts were 0.0015, 0.0026 and 0.0059% for studies A, B and C, respectively, which translates to mean percent recoveries of the absorbed 14C-amounts of 0.6, 1.4 and 0.5%.
- Details on excretion:
- - After cutaneous application means of 0.247, 0.187 and 1.207% of the applied 14C were recovered in the urine and feces within 72 hours in studies A, B and C, respectively. 14C was excreted mainly via urine (means of 89-92% of the eliminated amounts; 88-92% of the absorbed amounts); to a lesser extent it was eliminated via feces (means of 8-11% of the eliminated amounts). The mean excretion was fast: 91, 89 and 93% of the totally eliminated amounts were excreted in the first 24 hours after application in studies A, B and C, respectively.
Any other information on results incl. tables
Total recovery: Means of 96.0 – 99.7% of the applied 14C-doses were recovered in the various types of samples in studies A, B and C. Sex differences: In study A the mean 14C-amount in the application site sum of urine, sum of feces and cutaneous absorption were all higher in males but without gaining significance statistically. The 14C-concentrations found in the organs were in most cases slightly higher in males than in females. In study C, the mean 14C-amount found in the application site, sum of urine, sum of feces, carcass and cutaneous absorption were higher in males gaining significance only in urine 48 - 72 h post dose. The mean 14C-concentrations found in thyroids and carcass were significantly higher in males than in females.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: no bioaccumulation potential based on study results
Dermal absorption of 6-chloro-4-nitro-2-aminophenol (Chlororange) after 30 min of exposure was low. When absorbed; excretion took place mainly via the urine. Radioactivity in all analysed organs was near or below the detection limit 72 hours post-application. - Executive summary:
The absorption, distribution and excretion of 6-chloro-4-nitro-2-aminophenol (Chlororange) after dermal administration was determined by following the OECD guideline 417 (Toxicokinetics).
Male and female Sprague-Dawley (Him:OFA, SPF) rats (from Forschungsinstitut für Versuchstierzucht, A-2325 Himberg, Austria) weighing approximately 200 g were used in study. Animals were housed individually in metabolism cages. Animals were maintained under standard laboratory conditions (temperature: 21°C, humidity: 45%; Air changes: 10 air changes/ h; photoperiod: Artificial light from 6.00 a.m. to 6.00 p.m. / d).
Three studies (Studies A, B and C) were conducted using the radiolabeled test substance. In Studies A and B, formulations 1 and 2 were utilized, respectively. In Study C, a solution of test substance in water/DMSO was used. The details of test formulation/ solution were as follows:
- Formulation 1: Formulation without H2O2 containing 3% radiolabeled test substance.
- Formulation 2: Formulation with H2O2 containing 3% radiolabeled test substance.
- Solution of test substance: 9.99% solution of the radiolabeled test substance in water/DMSO (1:1).
3 rats/sex/study were allocated using a table of random numbers. The amount of test substance applied per animal was approximately 30.0 mg in each study. The test formulation or solution was applied to the clipped dorsal skin of rats for 30 min.
After treatment, the test substance was scraped and washed off and the skin rinsed with a shampoo. During the exposure time, animals were fixed to avoid licking. After rinsing, the area was covered with gauze fixed by adhesive tape and an additional air permeable plastic cone to further prevent licking of the treated area during the 72 h in the metabolism cages.
Urine and faeces were collected daily (0-24, 24-48 and 48-72 h p.a.) from the metabolism cages. Water from the daily rinsing of the cages was combined with urine. Faeces were mixed with water and then homogenized.
The animals were killed 72 hours after the application by exsanguination in anesthesia (Thiopental).
14C-radioactivity was determined in a liquid scintillation counter (Tri-Carb 300CD, Packard Instrument Co.) with automatic external standardization and protocols to subtract background counting rates and to compute quench corrected decay rates.
Following dermal application, the majority of the dyestuff was removed by rinsing 30 min after application, i.e., 95.4 to 98.7 % of the applied dose was found in the washing water. Seventy two hours after application, the amount of radioactivity remaining at the application site (skin) was less than 1 % for all three studies (A, B and C). The highest value (0.82 % of the applied dose) was noted for the formulation with H2O2 (Study B). For the formulation without H2O2 (Study A) and for the solution (DMSO/water; Study C), the figures were 0.38 and 0.59 %, respectively. The lowest absorption rate was obtained in the formulation containing H2O2
The proportion of the applied dose that was absorbed was calculated by adding the amounts in urine, faeces and carcass:
- A.Formulation without H2O2: 0.248 % (equal to 5.6 μg/cm²),
- B. Formulation with H2O2: 0.108 % (equal to 3.52 μg/cm²), and
- C.Pure dyestuff in water/DMSO: 1.213 % (equal to 40.0 μg/cm²).
After cutaneous application, all mean concentrations of 14C in the organs 72 hours post-dose were near or below the detection limits. In studies A to C the highest relative concentrations were noted in the thyroid (below detection limits) and kidney. The lowest concentrations were detected in lungs, brain and heart in study A and in testes, brain and muscle in studies B and C.
Means of 96.0 – 99.7% of the applied 14C-doses were recovered in studies A, B and C.
Based on above, dermal absorption of 6-chloro-4-nitro-2-aminophenol (Chlororange) after 30 min of exposure was low. When absorbed; excretion took place mainly via the urine. Radioactivity in all analysed organs was near or below the detection limit 72 hours post-application.
This toxicokinetics test is classified as acceptable, and satisfies the guideline requirements of the OECD 417 method.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.